ELMMB logo
Facebook logo Twitter logo
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 4th January 2022      MHRA Press Release Strong Steroid found in 'natural' skin cream. MHRA have issued a recall asking patients
                                     to return affected products.
11th Nov 2021           News Release Patient safety priority in recall of batches of cold and flu medicine with labelling error.
15th Sept 2021          MHRA Press Release The MHRA is advising anyone experiencing skin redness or burning sensations after
                                     they have stopped using these creams or ointments to seek advice from their health professional before
                                     using these products again.
 9th August 2021       MHRA Press Release MHRA recalls contaminated Irbesartan-batches as a precautionary measure. 
                                                                        Patients should not stop any treatments without consulting their doctor or pharmacist.
 8th July 2021             MHRA Press Release First progesterone-only contraceptive pills to be available to purchase from pharmacies      
 1st July 2021             Company led medicines recall: Morphine Syringe 50mg/50ml [unlicensed medicine] and Magnesium Sulphate
                                                                                         8mmol/20ml infusion [unlicensed medicine]
 17th June 2021         MHRA Press Release  MHRA recalls contaminated Irbesartan and Losartan batches as precautionary measure
 8th June 2021           MHRA Press Release  Over 3 million medicines and devices seized in UK as part of global crackdown
 28th May 2021         MHRA Press Release A personal trainer sentenced to 31 months in jail for selling and supplying unlicensed and                                                                                prescription medicines, together with Anabolic steroids, to the public.        
 4th May 2021           MHRA Press Release  MHRA announces appointment of Chief Safety Officer

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

application/pdfXomolix 2.5mg per ml soln for injection_ class 2 medicines recall_EL__21_A_15_Final__2 0721_.pdf (162KB)01/07/2021Download
 Kyowa Kirin Limited is recalling the above batches as a precautionary measure, due to the reports of glass and cellulose fibre contamination, which was identified during stability and reference... 
application/pdfIrbesartan Class 2 medicines recall June 21 EL__21_A_14_FINAL.pdf (128KB)18/06/2021Download
application/pdfCo-codamol 30_500mg eff NatPSA-2021-004-MHRA-PL_June 21.pdf (124KB)16/06/2021Download
 Zentiva Pharma UK Limited have notified the MHRA of an issue related to the homogeneity of a batch of Co-codamol 30/500 Effervescent Tablets that could result in a potential underdose and lack of... 
application/pdfSyonell 250_500mg tablets Class 4 meds recall EL__21_A_11 040521.pdf (78KB)04/05/2021Download
 Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets.... 
application/pdfTrimethorpim 200mg tab Class 2 meds recall EL__21_A_10_FINAL 220421.pdf (121KB)22/04/2021Download
 Ennogen Pharma Limited are recalling the above batch as a precautionary measure due to the investigation of market complaints. The Marketing Authorisation Holder has received two complaints related... 
application/pdfItraconazole 10mg per ml oral soln class 3 meds recallEL__21_A_08.pdf (91KB)15/03/2021Download
 Thame Laboratories are recalling the above batches due to an issue with the container closure (childresistant cap). The Marketing Authorisation Holder has received a number of complaints regarding... 
application/pdfEasyhaler Salbutabol Sulfate 100mcg & 200mcg per actuation inhaletion powder EL__21_A_06_Final.pdf (132KB)01/03/2021Download
 Orion Corporation T/A Orion Pharma (UK) Ltd are recalling the above batches as a precautionary measure due to an issue related to moulding defects in the bulk chambers where the inhalation powder is... 
application/pdfPalexia 20mg per ml oral soln Class 2 meds recall EL__21_A_02_Final 080221.pdf (178KB)08/02/2021Download
 Grünenthal Ltd has informed us of a potential microbial contamination during routine stability testing for the batches listed in this recall. Due to the detection of possible Burkholderia... 
application/pdfKolanticon Gel 500ml Class 3 meds recall_030221EL__21_A_01_Final.pdf (117KB)03/02/2021Download
 Brief description of the problem Intrapharm Laboratories Ltd has received a number of complaints that the product consistency is lumpy. The investigation has confirmed through review of the retained... 
application/pdfZerbaxa 1g_0.5g Powder for Conc for sol Class 2 Meds recall EL__20_A_60 171220.pdf (122KB)17/12/2020Download
 Merck Sharp & Dohme Limited is recalling the above batches due to the presence of Ralstonia pickettii in recent batches that were manufactured. The above batches are recalled as a precautionary... 
application/pdfCo-careldops 25_100mg Class 4 Medicines Recall EL__20_A_59_Final 151220.pdf (140KB)15/12/2020Download
 Fairmed Healthcare GmbH has informed us of a discrepancy on the product packaging for the above batches. The discrepancy relates to the incorrect spelling of one of the active pharmaceutical... 
application/pdfSimvador tablets Class 3 medicines recall 031220 EL__20_A_57i.pdf (118KB)03/12/2020Download
 Lupin Healthcare (UK) Limited has informed us that the affected batches above (also distributed by Discovery Pharmaceuticals/Dexcel Pharma Limited) have been packaged with a version of patient... 
Page: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10]